Related Experiment Videos
[Percutaneous intervention in the correction of congenital heart deffects (DCC): experience in as UMAE]
Vicente Campos-García1, Guillermo Ordóñez-Toquero2, Sarain Monjaraz-Rodríguez3
1Departamento de Cardiología Clínica, Hospital de Especialidades, UMAE Lic. Ignacio García Téllez, IMSS, Mérida, Yuc., México.
Introduction:
Congenital heart defects are common in infants and adults, affecting quality of life if not corrected. Unlike open surgery, percutaneous intervention allows correction with a high success rate and speedy recovery. In Mexico, there are not enough studies to describe their efficacy and safety.
Methods:
A cohort study was conducted in the Hospital "Manuel Avila Camacho", in Puebla, Mexico, including 149 patients with congenital heart defects repaired by percutaneous intervention, recording data from clinical records. The following were documented: post-guided fluoroscopy, hemodynamic changes, cardiac catheterization drilling anatomical changes, and complications six months later such as infection or bleeding at the puncture site, device migration, endocarditis, or death. SPSS was used, using descriptive and inferential statistics.
Results:
The patients' congenital heart defects treated were ductus arteriosus, atrial septal defect, and aortic coarctation, with ductus arteriosus being recorded as the most frequent congenital heart defect. Primary angioplasties were performed in 75% and stenting in the rest. Anatomical corrections of congenital defects were successful in 96.4% of patients (p < 0.01), with minimal adverse effects (p < 0.01).
Conclusions:
We conclude that our hospital has good efficacy and safety in percutaneous intervention, comparable to published reports.